Your browser doesn't support javascript.
loading
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
Dalerba, Piero; Sahoo, Debashis; Paik, Soonmyung; Guo, Xiangqian; Yothers, Greg; Song, Nan; Wilcox-Fogel, Nate; Forgó, Erna; Rajendran, Pradeep S; Miranda, Stephen P; Hisamori, Shigeo; Hutchison, Jacqueline; Kalisky, Tomer; Qian, Dalong; Wolmark, Norman; Fisher, George A; van de Rijn, Matt; Clarke, Michael F.
Affiliation
  • Dalerba P; From the Herbert Irving Comprehensive Cancer Center and the Departments of Pathology and Cell Biology and Medicine, Columbia University, New York (P.D.); Institute for Stem Cell Biology and Regenerative Medicine (P.D., D.S., P.S.R., S.P.M., S.H., J.H., D.Q., M.F.C.) and the Departments of Pathology (X.G., E.F., M.R.), and Medicine, Division of Oncology (N.W.-F., G.A.F., M.F.C.), Stanford University, Stanford, and the Departments of Pediatrics and Computer Science and Engineering, University of C
N Engl J Med ; 374(3): 211-22, 2016 Jan 21.
Article in En | MEDLINE | ID: mdl-26789870
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biomarkers, Tumor / Gene Expression / Colonic Neoplasms / Homeodomain Proteins / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: N Engl J Med Year: 2016 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biomarkers, Tumor / Gene Expression / Colonic Neoplasms / Homeodomain Proteins / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: N Engl J Med Year: 2016 Type: Article